Purpose
Gastric cancer is the second leading cause of cancer-related death worldwide. Although surgery is the standard curative treatment for gastric cancer, relapse occurs in a large number of patients, except in the case of early diagnosed gastric cancer. Following previous studies that identified endoplasmic reticulum oxidoreductin 1-α (ERO1L) as a potential marker for gastric cancer, we investigated the functional role of ERO1L in gastric cancer.
Materials and Methods
For validation of microarray data, the mRNA expression level of ERO1L was measured by quantitative real-time reverse transcription polymerase chain reaction in 56 independent stage III gastric cancer patients. Immunohistochemical staining was performed to examine the protein expression level of ERO1L in 231 gastric cancer patients. Correlation between gene expression and cancer prognosis was evaluated.
Results
Patients with high ERO1L expression had poorer survival than those with low expression (p < 0.01). Functional assays demonstrated that ERO1L knockdown inhibited cell proliferation, migration, invasion, and chemoresistance. In addition, involvement of inactivation of Akt and JNK signaling in molecular mechanisms of ERO1L inhibition was demonstrated.
Conclusion
High expression of ERO1L is associated with poor prognosis of patients with gastric cancer. These results indicate that ERO1L expression may be a clinically promising therapeutic target for prevention of gastric cancer.
Citations
Citations to this article as recorded by
Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer Peng Chen, Amit Sharma, Hans Weiher, Ingo G.H. Schmidt-Wolf Journal of Experimental & Clinical Cancer Research.2024;[Epub] CrossRef
Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma Xuebing Zhou, Yuan Li, Chunyu Yang, Dan Chen, Tong Wang, Tesi Liu, Wendi Yan, Zhaoxia Su, Bosen Peng, Xiangshan Ren Life Sciences.2023; 327: 121698. CrossRef
ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway Min Wu, Ruixue Li, Jianyan Qin, Ziyuan Wang, Jiasen Guo, Fenghong Lv, Guoqin Wang, Youguang Huang Journal of Molecular Histology.2023; 54(6): 621. CrossRef
Identification of novel small molecule inhibitors for endoplasmic reticulum oxidoreductase 1α (ERO1α) enzyme: structure-based molecular docking and molecular dynamic simulation studies Hussam Albassam, Chetan H. Mehta, Usha Y. Nayak Journal of Biomolecular Structure and Dynamics.2022; 40(23): 13218. CrossRef
MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha Gang Chen, Qihao Wang, Kunyu Wang Bioengineered.2022; 13(4): 10061. CrossRef
ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/β‐catenin signaling pathway Jinbao Xie, Guoliang Liao, Zhi Feng, Bo Liu, Xu Li, Minglian Qiu Molecular Carcinogenesis.2022; 61(10): 897. CrossRef
Current therapeutic options for gastric adenocarcinoma C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad Saudi Journal of Biological Sciences.2021; 28(9): 5371. CrossRef
circ‑ACACA promotes proliferation, invasion, migration and glycolysis of cervical cancer cells by targeting the miR‑582‑5p/ERO1A signaling axis Dandan Huang, Cuimei Li Oncology Letters.2021;[Epub] CrossRef
Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients Li Li, Xiaodong Yin, Hai Meng, Juanyu Hu, Zhengqing Yu, Jianyong Xu Yonsei Medical Journal.2020; 61(1): 15. CrossRef
Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities Zifeng Song, Martin C. Pearce, Yuan Jiang, Liping Yang, Cheri Goodall, Cristobal L. Miranda, Milan Milovancev, Shay Bracha, Siva K. Kolluri, Claudia S. Maier Scientific Reports.2020;[Epub] CrossRef
Role of the ERO1-PDI interaction in oxidative protein folding and disease Andrea G. Shergalis, Shuai Hu, Armand Bankhead, Nouri Neamati Pharmacology & Therapeutics.2020; 210: 107525. CrossRef
Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer Qing Tao, Wen Zhu, Xiaohui Zhao, Mei Li, Yongqian Shu, Deqiang Wang, Xiaoqin Li Frontiers in Oncology.2020;[Epub] CrossRef
ERO1L promotes NSCLC development by modulating cell cycle‐related molecules Xiujuan Shi, Jiawen Wu, Yi Liu, Yuxiong Jiang, Changjiang Zhi, Jue Li Cell Biology International.2020; 44(12): 2473. CrossRef
ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells Yuanyuan lei, Ruochuan Zang, Zhiliang Lu, Guochao Zhang, Jianbing Huang, Chengming Liu, Zhanyu Wang, Shuangshuang Mao, Yun Che, Xinfeng Wang, Sufei Zheng, Lingling Fang, Nan Sun, Jie He Cell Death & Disease.2020;[Epub] CrossRef
Hypoxia and Reactive Oxygen Species as Modulators of Endoplasmic Reticulum and Golgi Homeostasis Daniela Mennerich, Sakari Kellokumpu, Thomas Kietzmann Antioxidants & Redox Signaling.2019; 30(1): 113. CrossRef
Endoplasmic reticulum proteostasis control and gastric cancer Yu Wang, Kai Wang, Yang Jin, Xia Sheng Cancer Letters.2019; 449: 263. CrossRef
Analysis of the characteristics and expression profiles of coding and noncoding RNAs of human dental pulp stem cells in hypoxic conditions Ruitang Shi, Haoqing Yang, Xiao Lin, Yangyang Cao, Chen Zhang, Zhipeng Fan, Benxiang Hou Stem Cell Research & Therapy.2019;[Epub] CrossRef
A2ML1and otitis media: novel variants, differential expression, and relevant pathways Eric D. Larson, Jose Pedrito M. Magno, Matthew J. Steritz, Erasmo Gonzalo d.V. Llanes, Jonathan Cardwell, Melquiadesa Pedro, Tori Bootpetch Roberts, Elisabet Einarsdottir, Rose Anne Q. Rosanes, Christopher Greenlee, Rachel Ann P. Santos, Ayesha Yousaf, Sv Human Mutation.2019;[Epub] CrossRef
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells Anastasiya V. Snezhkina, Anna V. Kudryavtseva, Olga L. Kardymon, Maria V. Savvateeva, Nataliya V. Melnikova, George S. Krasnov, Alexey A. Dmitriev Oxidative Medicine and Cellular Longevity.2019; 2019: 1. CrossRef
Control of Protein Homeostasis in the Early Secretory Pathway: Current Status and Challenges Daria Sicari, Aeid Igbaria, Eric Chevet Cells.2019; 8(11): 1347. CrossRef
ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer Nikhil Gupta, Jung Eun Park, Wilford Tse, Jee Keem Low, Oi Lian Kon, Neil McCarthy, Siu Kwan Sze Oncotarget.2019; 10(57): 5970. CrossRef
Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology Olga A. Smirnova, Birke Bartosch, Natalia F. Zakirova, Sergey N. Kochetkov, Alexander V. Ivanov International Journal of Molecular Sciences.2018; 19(4): 1219. CrossRef
Combined expression of protein disulfide isomerase and endoplasmic reticulum oxidoreductin 1‑α is a poor prognostic marker for non‑small cell lung cancer Kyoung Kim, Ae An, Ho Park, Kyu Jang, Woo Moon, Myoung Kang, Yong Lee, Ja Ku, Myoung Chung Oncology Letters.2018;[Epub] CrossRef
High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrence Toshio Sakatani, Keita Maemura, Noriko Hiyama, Yosuke Amano, Kousuke Watanabe, Hidenori Kage, Masashi Fukayama, Jun Nakajima, Yutaka Yatomi, Takahide Nagase, Daiya Takai Japanese Journal of Clinical Oncology.2017; 47(6): 543. CrossRef
Omics technologies in diagnosis of lung adenocarcinoma S. E. Novikova, L. K. Kurbatov, M. G. Zavialova, V. G. Zgoda, A. I. Archakov Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry.2017; 11(4): 309. CrossRef
Expression of ERO1L in gastric cancer and its association with patient prognosis Bo Zhou, Gongping Wang, Shegan Gao, Ye Chen, Canhui Jin, Zengfang Wang, Yantong Yang, Zhikun Ma, Wei Zhang, Xiaoshan Feng Experimental and Therapeutic Medicine.2017; 14(3): 2298. CrossRef